JP Morgan Chase
ZBH icon

JP Morgan Chase’s Zimmer Biomet ZBH Stock Holding History

JP Morgan Chase’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-33,800
Closed -$3.57M – 7796
2024
Q4 		$3.57M Sell
33,800
-5,500
-14% -$590K ﹤0.01% 3669
2024
Q3 		$4.24M Hold
39,300
– – ﹤0.01% 3331
2024
Q2 		$4.27M Sell
39,300
-40,000
-50% -$4.72M ﹤0.01% 3152
2024
Q1 		$10.5M Buy
79,300
+5,500
+7% +$687K ﹤0.01% 2435
2023
Q4 		$8.98M Buy
+73,800
New +$8.23M ﹤0.01% 2590
2016
Q4 		– Sell
-66,950
Closed -$8.45M – 5160
2016
Q3 		$8.45M Buy
+66,950
New +$8.27M ﹤0.01% 1895

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase's ZBH Position: Q2 2026 in Review

JP Morgan Chase reduced its Zimmer Biomet (ZBH) stake by 1.5% in Q2 2026, selling an estimated $1.1M and leaving 815,914 shares worth $74.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1213.

JP Morgan Chase first reported a position in ZBH in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.69B in Q3 2021. 907 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • JP Morgan Chase held 815,914 shares of Zimmer Biomet worth $74.4M as of Q2 2026.
  • JP Morgan Chase sold 12,506 Zimmer Biomet shares in Q2 2026, an estimated $1.1M.
  • Zimmer Biomet made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #1213 holding.
  • JP Morgan Chase first reported a position in Zimmer Biomet in Q2 2013 and has held it in 53 quarters since.
  • JP Morgan Chase's Zimmer Biomet position peaked at $1.69B in Q3 2021.
  • 907 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.